ZYXI
$14.52
Zynex
($2.90)
(16.65%)
ZYXI
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  $0.06
Revenue:  N/A
Thursday
May 27
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ZYXI reports earnings?
Beat
Meet
Miss

Where is ZYXI's stock price going from here?
Up
Flat
Down
Stock chart of ZYXI
Analysts
Summary of analysts' recommendations for ZYXI
Score
Grade
Pivots
Resistance
$17.99
$17.09
$15.81

$14.91

Support
$13.63
$12.73
$11.45
Tweet
Growth
Description
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Peers
MedtronicVarian Medical SystemsCONMED